Phase 3 Recruiting Network
This phase III trial compares the effect of cabozantinib versus combination dabrafenib and trametinib for the treatment of patients with differentiated thyroid cancer that does not respond to treatment (refractory) and which expresses a BR…
Sponsor: ECOG-ACRIN Cancer Research Group
NCT ID: NCT06475989
Sites in Minnesota: - Sanford Joe Lueken Cancer Center — Bemidji, Minnesota
- Minnesota Oncology - Burnsville — Burnsville, Minnesota
- Cambridge Medical Center — Cambridge, Minnesota
- Mercy Hospital — Coon Rapids, Minnesota
- Fairview Southdale Hospital — Edina, Minnesota
Phase 1, Phase 2 Recruiting Industry
Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective dose and recommended Phase 2 dose (RP2D) of repotrectinib given to adult subjects with adv…
Sponsor: Turning Point Therapeutics, Inc.
NCT ID: NCT03093116
Sites in Minnesota: - Local Institution - 2132 — Saint Paul, Minnesota
Phase 1, Phase 2 Recruiting Academic/Other
BDTX-4933-101 is a first-in-human, open-label, Phase 1/2 dose escalation, dose optimization and expansion study designed to evaluate the safety and tolerability of S241656 as monotherapy and in combination with other anti-cancer therapies …
Sponsor: Institut de Recherches Internationales Servier
NCT ID: NCT05786924
Sites in Minnesota: - Masonic Cancer Center University of Minnesota — Minneapolis, Minnesota
Phase 1 Recruiting Industry
The purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) alone or in combination as a potential cancer treatment for adults with advanced solid tumors. The study will be conducted in two par…
Sponsor: Pfizer
NCT ID: NCT05538130
Sites in Minnesota: - HealthPartners Frauenshuh Cancer Center — Saint Louis Park, Minnesota
- Methodist Hospital Inpatient Pharmacy — Saint Louis Park, Minnesota
- HealthPartners Cancer Center at regions Hospital — Saint Paul, Minnesota
- Regions Hospital Pharmacy — Saint Paul, Minnesota
Recruiting Academic/Other
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…
Sponsor: Alliance for Clinical Trials in Oncology
NCT ID: NCT05334069
Sites in Minnesota: - Riverwood Healthcare Center — Aitkin, Minnesota
- Mayo Clinic Health System in Albert Lea — Albert Lea, Minnesota
- Essentia Health - Baxter Clinic — Baxter, Minnesota
- Sanford Joe Lueken Cancer Center — Bemidji, Minnesota
- Essentia Health Saint Joseph's Medical Center — Brainerd, Minnesota
NA Recruiting Network
The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.
Sponsor: Eastern Cooperative Oncology Group
NCT ID: NCT05108298
Sites in Minnesota: - Fairview Ridges Hospital — Burnsville, Minnesota
- Minnesota Oncology - Burnsville — Burnsville, Minnesota
- Cambridge Medical Center — Cambridge, Minnesota
- Mercy Hospital — Coon Rapids, Minnesota
- Fairview Southdale Hospital — Edina, Minnesota
Recruiting Academic/Other
The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, h…
Sponsor: University of Nebraska
NCT ID: NCT02012699
Sites in Minnesota: - Riverwood Healthcare Center — Aitkin, Minnesota
- Essentia Health-St. Joseph's Medical Center — Brainerd, Minnesota
- Essentia Health - Duluth Clinic — Duluth, Minnesota
- St. Luke's Hospital of Duluth — Duluth, Minnesota
- Lake Region Healthcare — Fergus Falls, Minnesota
Recruiting Industry
This is an observational case-control study to train and validate a genome-wide methylome enrichment platform to detect multiple cancer types and to differentiate amongst cancer types. The cancers included in this study are brain, breast, …
Sponsor: Adela, Inc
NCT ID: NCT05366881
Sites in Minnesota: - Allina Health Cancer Institute — Minneapolis, Minnesota
- Mayo Clinic — Rochester, Minnesota
Recruiting Academic/Other
This study is being done to identify and differentiate thyroid nodules by acoustic imaging and viscoelastic parameters.
Sponsor: Mayo Clinic
NCT ID: NCT06207188
Sites in Minnesota: - Mayo Clinic in Rochester — Rochester, Minnesota
Recruiting Academic/Other
This phase II study evaluates F-18 tetrafluoroborate (18F-TFB) PET/CT scan in patients with differentiated thyroid cancer. Diagnostic imaging is necessary for planning treatment, monitoring therapy response, and identifying sites of recurr…
Sponsor: Mayo Clinic
NCT ID: NCT05575440
Sites in Minnesota: - Mayo Clinic in Rochester — Rochester, Minnesota
Recruiting Academic/Other
Pleuropulmonary blastoma (PPB) is a rare malignant neoplasm of the lung presenting in early childhood. Type I PPB is a purely cystic lesion, Type II is a partially cystic, partially solid tumor, Type III is a completely solid tumor. Treatm…
Sponsor: Children's Hospitals and Clinics of Minnesota
NCT ID: NCT03382158
Sites in Minnesota: - Children's Minnesota — Minneapolis, Minnesota
Recruiting Academic/Other
The purpose of this research is to identify a biomarker that is exists when human papillomavirus (HPV) mediated oropharyngeal squamous cell carcinoma is present and does not exist when HPV mediated oropharyngeal squamous cell carcinoma is …
Sponsor: Mayo Clinic
NCT ID: NCT06356272
Sites in Minnesota: - Mayo Clinic in Rochester — Rochester, Minnesota